首页 > 最新文献

Journal of Research in Pharmacy and Pharmaceutical Sciences最新文献

英文 中文
SYNERGISTIC EFFECT OF COMBINATION BETWEEN CYANOMACLURIN AND ARTOCARPIN FROM ARTOCARPUS HETEROPHYLLUS HEARTWOODS AGAINSTS STREPTOCOCCUS PYOGENES AND STAPHYLOCOCCUS EPIDERMIDIS 杨桃心材杨桃素与杨桃素联合抗化脓性链球菌和表皮葡萄球菌的增效作用
Pub Date : 2022-06-27 DOI: 10.33533/jrpps.v1i1.4250
A. Septama, Eldiza Puji Rahmi, M.Sc
Streptococcus pyogenes and Staphylococcus epidermidis are major problem of human health and may generate antibacterial resistance problem. Flavonoid has been used for the treatment of several ailments including bacterial infection. Artocarpus heterophyllus is a potential source of flavonoid compounds such as artocarpin and cyanomaclurin. The study was conducted to observe synergistic effects between flavonoid compounds against S. pyogenes and S. epidermidis. The antibacterial activity of combination of artocarpin and cyanomaclurin isolated from A. heterophyllus heartwoods were evaluated against S. pyogenes and S. epidermidis using broth microdilution methods. Interaction between two compounds in combination was determined using checkerboard assay. Artocarpin showed strong antibacterial activity with MIC value of 1.9 µg/mL. Cyanomaclurin only exhibited moderate activity with MIC value of 15.6 µg/mL. The mixture of compounds in several ratios tended to increase antibacterial activities of cyanomaclurin. There is no antagonistic effect when compounds used together. It can be concluded that flavonoid compounds in combination may enhance antibacterial activity to prevent development of antibacterial resistance.
化脓性链球菌和表皮葡萄球菌是人类健康的主要问题,可能产生耐药性问题。类黄酮已被用于治疗包括细菌感染在内的几种疾病。胡杖是一种潜在的黄酮类化合物来源,如胡杖素和氰马柳苷。研究了黄酮类化合物对化脓性葡萄球菌和表皮葡萄球菌的协同作用。采用微量肉汤稀释法,研究了杂叶松心材中分离的蒿卡素和氰马柳苷联合对化脓性葡萄球菌和表皮葡萄球菌的抑菌活性。采用棋盘法测定两种化合物的相互作用。阿托卡宾具有较强的抗菌活性,MIC值为1.9 μ g/mL。Cyanomaclurin仅表现出中等活性,MIC值为15.6µg/mL。不同配比的混合物均有提高氰马柳啉抑菌活性的趋势。两种化合物合用无拮抗作用。综上所述,黄酮类化合物联合使用可增强抗菌活性,防止细菌产生耐药性。
{"title":"SYNERGISTIC EFFECT OF COMBINATION BETWEEN CYANOMACLURIN AND ARTOCARPIN FROM ARTOCARPUS HETEROPHYLLUS HEARTWOODS AGAINSTS STREPTOCOCCUS PYOGENES AND STAPHYLOCOCCUS EPIDERMIDIS","authors":"A. Septama, Eldiza Puji Rahmi, M.Sc","doi":"10.33533/jrpps.v1i1.4250","DOIUrl":"https://doi.org/10.33533/jrpps.v1i1.4250","url":null,"abstract":"Streptococcus pyogenes and Staphylococcus epidermidis are major problem of human health and may generate antibacterial resistance problem. Flavonoid has been used for the treatment of several ailments including bacterial infection. Artocarpus heterophyllus is a potential source of flavonoid compounds such as artocarpin and cyanomaclurin. The study was conducted to observe synergistic effects between flavonoid compounds against S. pyogenes and S. epidermidis. The antibacterial activity of combination of artocarpin and cyanomaclurin isolated from A. heterophyllus heartwoods were evaluated against S. pyogenes and S. epidermidis using broth microdilution methods. Interaction between two compounds in combination was determined using checkerboard assay. Artocarpin showed strong antibacterial activity with MIC value of 1.9 µg/mL. Cyanomaclurin only exhibited moderate activity with MIC value of 15.6 µg/mL. The mixture of compounds in several ratios tended to increase antibacterial activities of cyanomaclurin. There is no antagonistic effect when compounds used together. It can be concluded that flavonoid compounds in combination may enhance antibacterial activity to prevent development of antibacterial resistance.","PeriodicalId":398630,"journal":{"name":"Journal of Research in Pharmacy and Pharmaceutical Sciences","volume":"134 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131519503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ANTIBACTERIAL ACTIVITY TEST OF BAY LEAF EXTRACTS (SYZYGIUM POLYANTHUM (WIGHT) WALP.) AGAINST STAPHYLOCOCCUS AUREUS AND ESCHERICHIA COLI: SYSTEMATIC LITERATURE REVIEW 月桂叶提取物的抑菌活性试验抗金黄色葡萄球菌和大肠杆菌:系统文献综述
Pub Date : 2022-06-27 DOI: 10.33533/jrpps.v1i1.4460
Gladys Imanda Sapoetri, R. Revina, A. Muti
Antibiotic resistance is a global health problem that has severe implications for morbidity, mortality, and health costs. Based on the Antimicrobial Resistant in Indonesia (AMRIN-Study), it was reported that there were bacteria that were resistant to antibiotics, including Escherichia coli, which is resistant to ampicillin trimethoprim-sulfamethoxazole and ciprofloxacin; and Staphylococcus aureus which is resistant to oxacillin, vancomycin, clindamycin, and levofloxacin. In Indonesia, Syzygium polyanthum (Wight) Walp. Bay leaf is one of the plants that is often used as spices. Its bay leaf contains secondary metabolites that have an antibacterial function. This study analyzed the antibacterial activities of bay leaf extract against Staphylococcus aureus and Escherichia coli. This research used a systematic literature review with a literature search strategy using Google Scholar and PubMed. The literature discusses bay leaf extract, Staphylococcus aureus, Escherichia coli, and antibacterial activity. From this study, 14 research articles described the antibacterial activity of bay leaf extract by inhibiting the growth of Staphylococcus aureus and Escherichia coli in the medium, strong, and very strong categories. Bay leaf extract can inhibit the growth of Staphylococcus aureus and Escherichia coli because it contains phytochemical compounds with antibacterial properties, including alkaloids, flavonoids, steroids/ triterpenoids, saponins, tannins, phenols, essential oils, and carbohydrate.
抗生素耐药性是一个全球性的健康问题,对发病率、死亡率和卫生费用都有严重影响。根据印度尼西亚的抗微生物药物耐药性研究(AMRIN-Study),报告存在对抗生素耐药的细菌,包括对氨苄西林-甲氧苄啶-磺胺甲恶唑和环丙沙星耐药的大肠杆菌;金黄色葡萄球菌耐氧西林、万古霉素、克林霉素和左氧氟沙星。在印度尼西亚,白杨(Syzygium polyanthum (Wight) Walp。月桂叶是一种经常用作香料的植物。其月桂叶含有具有抗菌功能的次生代谢物。本研究分析了月桂叶提取物对金黄色葡萄球菌和大肠杆菌的抑菌活性。本研究采用了系统的文献综述和文献搜索策略,使用了Google Scholar和PubMed。文献讨论了月桂叶提取物,金黄色葡萄球菌,大肠杆菌和抗菌活性。从本研究中,有14篇研究文章描述了月桂叶提取物的抑菌活性,包括抑制金黄色葡萄球菌和大肠杆菌生长的中、强、强三类。月桂叶提取物可以抑制金黄色葡萄球菌和大肠杆菌的生长,因为它含有具有抗菌特性的植物化学化合物,包括生物碱、类黄酮、类固醇/三萜、皂苷、单宁、酚类、精油和碳水化合物。
{"title":"ANTIBACTERIAL ACTIVITY TEST OF BAY LEAF EXTRACTS (SYZYGIUM POLYANTHUM (WIGHT) WALP.) AGAINST STAPHYLOCOCCUS AUREUS AND ESCHERICHIA COLI: SYSTEMATIC LITERATURE REVIEW","authors":"Gladys Imanda Sapoetri, R. Revina, A. Muti","doi":"10.33533/jrpps.v1i1.4460","DOIUrl":"https://doi.org/10.33533/jrpps.v1i1.4460","url":null,"abstract":"Antibiotic resistance is a global health problem that has severe implications for morbidity, mortality, and health costs. Based on the Antimicrobial Resistant in Indonesia (AMRIN-Study), it was reported that there were bacteria that were resistant to antibiotics, including Escherichia coli, which is resistant to ampicillin trimethoprim-sulfamethoxazole and ciprofloxacin; and Staphylococcus aureus which is resistant to oxacillin, vancomycin, clindamycin, and levofloxacin. In Indonesia, Syzygium polyanthum (Wight) Walp. Bay leaf is one of the plants that is often used as spices. Its bay leaf contains secondary metabolites that have an antibacterial function. This study analyzed the antibacterial activities of bay leaf extract against Staphylococcus aureus and Escherichia coli. This research used a systematic literature review with a literature search strategy using Google Scholar and PubMed. The literature discusses bay leaf extract, Staphylococcus aureus, Escherichia coli, and antibacterial activity. From this study, 14 research articles described the antibacterial activity of bay leaf extract by inhibiting the growth of Staphylococcus aureus and Escherichia coli in the medium, strong, and very strong categories. Bay leaf extract can inhibit the growth of Staphylococcus aureus and Escherichia coli because it contains phytochemical compounds with antibacterial properties, including alkaloids, flavonoids, steroids/ triterpenoids, saponins, tannins, phenols, essential oils, and carbohydrate.","PeriodicalId":398630,"journal":{"name":"Journal of Research in Pharmacy and Pharmaceutical Sciences","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117132577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NARRATIVE REVIEW: COST-EFFECTIVENESS ANALYSIS OF THE USE OF ORAL ANTIDIABETIC DRUGS BIGUANIDE AND SULFONYLUREA GROUP IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 叙述性综述:口服降糖药双胍和磺脲类药物治疗2型糖尿病患者的成本-效果分析
Pub Date : 2022-06-27 DOI: 10.33533/jrpps.v1i1.4046
Kezia Ivana, D. C. Pradana, Citra Ayu Aprilia
Diabetes Mellitus requires long-term management at a considerable cost. Therefore, a cost-Effectiveness analysis was used to assess several health interventions. Biguanide and Sulfonylurea provided the best results at the cheapest cost in this study. This study aims to gain a supporting theoretical foundation regarding the cost-effectiveness of using oral antidiabetic drugs biguanide and sulfonylureas in patients with type 2 diabetes mellitus. The method used in this study is a Narrative Review using literature that discusses the cost-effectiveness of oral antidiabetic drugs biguanide and sulfonylureas in patients with type 2 diabetes mellitus. Based on the results of this study, the age range of the occurrence of Type 2 Diabetes Mellitus is 45-65 years, with more percentage of male patients than women and a common complication is hypertension. In this study, the use of the biguanide drug (Metformin) was shown to provide a significant reduction in blood sugar levels at a reasonably low cost. The ICER results showed that combination drugs increased additional costs, but their use was more effective in healing and improving patients' quality of life. In conclusion to this study, the use of biguanide and sulfonylurea groups proved cost-effective compared to other antidiabetic drugs.
糖尿病需要长期治疗,费用相当高。因此,成本效益分析用于评估若干卫生干预措施。双胍和磺酰脲在本研究中以最便宜的成本提供了最好的结果。本研究旨在为2型糖尿病患者口服降糖药双胍和磺脲类药物的成本-效果提供理论支持。本研究采用记叙性综述的方法,利用文献讨论口服降糖药双胍和磺脲类药物治疗2型糖尿病患者的成本-效果。根据本研究结果,2型糖尿病的发病年龄范围为45-65岁,男性患者比例高于女性,常见并发症为高血压。在这项研究中,双胍类药物(二甲双胍)的使用被证明可以以相当低的成本显著降低血糖水平。ICER结果显示,联合用药增加了额外的费用,但在治疗和改善患者生活质量方面更有效。本研究的结论是,与其他降糖药物相比,双胍和磺脲类药物的使用证明具有成本效益。
{"title":"NARRATIVE REVIEW: COST-EFFECTIVENESS ANALYSIS OF THE USE OF ORAL ANTIDIABETIC DRUGS BIGUANIDE AND SULFONYLUREA GROUP IN PATIENTS WITH TYPE 2 DIABETES MELLITUS","authors":"Kezia Ivana, D. C. Pradana, Citra Ayu Aprilia","doi":"10.33533/jrpps.v1i1.4046","DOIUrl":"https://doi.org/10.33533/jrpps.v1i1.4046","url":null,"abstract":"Diabetes Mellitus requires long-term management at a considerable cost. Therefore, a cost-Effectiveness analysis was used to assess several health interventions. Biguanide and Sulfonylurea provided the best results at the cheapest cost in this study. This study aims to gain a supporting theoretical foundation regarding the cost-effectiveness of using oral antidiabetic drugs biguanide and sulfonylureas in patients with type 2 diabetes mellitus. The method used in this study is a Narrative Review using literature that discusses the cost-effectiveness of oral antidiabetic drugs biguanide and sulfonylureas in patients with type 2 diabetes mellitus. Based on the results of this study, the age range of the occurrence of Type 2 Diabetes Mellitus is 45-65 years, with more percentage of male patients than women and a common complication is hypertension. In this study, the use of the biguanide drug (Metformin) was shown to provide a significant reduction in blood sugar levels at a reasonably low cost. The ICER results showed that combination drugs increased additional costs, but their use was more effective in healing and improving patients' quality of life. In conclusion to this study, the use of biguanide and sulfonylurea groups proved cost-effective compared to other antidiabetic drugs.","PeriodicalId":398630,"journal":{"name":"Journal of Research in Pharmacy and Pharmaceutical Sciences","volume":"75 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132474374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
THE EFFECTIVITY OF TRIPLE THERAPY COMPOSITION ON DYSPEPSIA WITH HELICOBACTER PYLORI INFECTION: A SYSTEMATIC REVIEW 三联疗法组合治疗幽门螺杆菌感染合并消化不良的疗效:系统综述
Pub Date : 2022-06-27 DOI: 10.33533/jrpps.v1i1.4441
Theodora Putri Simanjaya, Erna Harfiani, Mila Citrawati
Dyspepsia is a disease with one or more symptoms relating to abnormalities in gastroduodenal. One of the factors that influence dyspepsia is Helicobacter pylori (H. pylori). Clarithromycin-based triple therapy is recommended as first line eradication treatment. Resistance towards clarithromycin is increasing and causing eradication rates in Clarithromycin-based triple therapy to decrease. The purpose of this study was to determine the effectiveness of triple therapy variation on dyspepsia with H. pylori infection. Data was collected through literature searches on two different databases using the preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) 2020. This systematic review included all relevant articles from 2011-2021. Six studies met the inclusion criteria. The results showed that metronidazole-based triple therapy is effective in eradicating H. pylori due to its eradication rate surpassing the target rate of 80%. The highest eradication rates in intention-to-treat (ITT) and per-protocol (PP) were 94.3% and 93.5%, respectively. The best triple therapy composition is metronidazole-based triple therapy with 7 days of duration.
消化不良是一种伴有一种或多种与胃十二指肠异常有关的症状的疾病。影响消化不良的因素之一是幽门螺杆菌(h.p ylori)。克拉霉素三联疗法建议作为一线根除治疗。对克拉霉素的耐药性正在增加,导致克拉霉素三联疗法的根除率下降。本研究的目的是确定三联疗法对幽门螺杆菌感染的消化不良的疗效。使用首选的系统评价和荟萃分析方案报告项目(PRISMA-P) 2020通过两个不同数据库的文献检索收集数据。本系统综述纳入了2011-2021年的所有相关文章。6项研究符合纳入标准。结果表明,甲硝唑三联疗法对幽门螺杆菌的根除率超过80%,是有效的。意向治疗(ITT)和每个方案(PP)的最高根除率分别为94.3%和93.5%。最好的三联治疗组合是以甲硝唑为基础的三联治疗,持续时间为7天。
{"title":"THE EFFECTIVITY OF TRIPLE THERAPY COMPOSITION ON DYSPEPSIA WITH HELICOBACTER PYLORI INFECTION: A SYSTEMATIC REVIEW","authors":"Theodora Putri Simanjaya, Erna Harfiani, Mila Citrawati","doi":"10.33533/jrpps.v1i1.4441","DOIUrl":"https://doi.org/10.33533/jrpps.v1i1.4441","url":null,"abstract":"Dyspepsia is a disease with one or more symptoms relating to abnormalities in gastroduodenal. One of the factors that influence dyspepsia is Helicobacter pylori (H. pylori). Clarithromycin-based triple therapy is recommended as first line eradication treatment. Resistance towards clarithromycin is increasing and causing eradication rates in Clarithromycin-based triple therapy to decrease. The purpose of this study was to determine the effectiveness of triple therapy variation on dyspepsia with H. pylori infection. Data was collected through literature searches on two different databases using the preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) 2020. This systematic review included all relevant articles from 2011-2021. Six studies met the inclusion criteria. The results showed that metronidazole-based triple therapy is effective in eradicating H. pylori due to its eradication rate surpassing the target rate of 80%. The highest eradication rates in intention-to-treat (ITT) and per-protocol (PP) were 94.3% and 93.5%, respectively. The best triple therapy composition is metronidazole-based triple therapy with 7 days of duration.","PeriodicalId":398630,"journal":{"name":"Journal of Research in Pharmacy and Pharmaceutical Sciences","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116558398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ANTIMICROBIAL EFFECTIVENESS OF APPLE CIDER VINEGAR IN THE GROWTH OF Staphylococcus epidermidis and Propionibacterium acnes 苹果醋对表皮葡萄球菌和痤疮丙酸杆菌生长的抑菌效果
Pub Date : 2022-06-27 DOI: 10.33533/jrpps.v1i1.4171
I. Prabowo, Arifa Shaliha, Oktania Sandra Puspita
Acne is a skin disease caused by Propionibacterium acnes, Staphylococcus epidermidis-, and Staphylococcus aureus-induced inflammation. Apple cider vinegar contains antibacterial compounds such as acetic acid, chlorogenic acid, polyphenols, alkaloids, flavonoids, and glycosides. This study is conducted to determine the effectiveness of antibacterial compounds contained in apple cider vinegar against the growth of S.epidermidis and P.acnes, in vitro. The study used the disc diffusion method by utilizing the Mueller Hinton Agar medium. The apple cider vinegar inhibition zone was formed at the concentration of 25%, 50%, 75%, and 100% against the growth of P.acnes, whereas the inhibition zone against S.epidermidis was formed at the concentration of 50%, 75%, and 100%. The highest inhibition zone against P. acnes was 8,825 mm and against S.epidermidis was 3,725 mm at the concentration of 75%. Test results One-way ANOVA on P.acnes and Kruskal Wallis to S.epidermidis obtained (p) <0,005. This study concludes the effectiveness of apple cider vinegar in inhibiting the growth of P. acnes and S. epidermidis, where the effectiveness against P. acnes was stronger than against S. epidermidis.
痤疮是由痤疮丙酸杆菌、表皮葡萄球菌和金黄色葡萄球菌引起的炎症引起的一种皮肤病。苹果醋含有抗菌化合物,如醋酸、绿原酸、多酚、生物碱、类黄酮和糖苷。本研究旨在研究苹果醋中抗菌成分对表皮葡萄球菌和痤疮假单胞菌生长的体外抑制作用。本研究采用Mueller Hinton琼脂培养基的圆盘扩散法。25%、50%、75%和100%浓度的苹果醋对痤疮假丝酵母生长形成抑制带,50%、75%和100%浓度的苹果醋对表皮假丝酵母生长形成抑制带。当浓度为75%时,对痤疮假单胞菌和表皮假单胞菌的抑制面积分别为8825 mm和3725 mm。检验结果痤疮棘球蚴与表皮棘球蚴的单因素方差分析(p) < 0.005。结果表明,苹果醋对痤疮假丝酵母和表皮假丝酵母均有抑制作用,其中对痤疮假丝酵母的抑制作用强于对表皮假丝酵母的抑制作用。
{"title":"ANTIMICROBIAL EFFECTIVENESS OF APPLE CIDER VINEGAR IN THE GROWTH OF Staphylococcus epidermidis and Propionibacterium acnes","authors":"I. Prabowo, Arifa Shaliha, Oktania Sandra Puspita","doi":"10.33533/jrpps.v1i1.4171","DOIUrl":"https://doi.org/10.33533/jrpps.v1i1.4171","url":null,"abstract":"Acne is a skin disease caused by Propionibacterium acnes, Staphylococcus epidermidis-, and Staphylococcus aureus-induced inflammation. Apple cider vinegar contains antibacterial compounds such as acetic acid, chlorogenic acid, polyphenols, alkaloids, flavonoids, and glycosides. This study is conducted to determine the effectiveness of antibacterial compounds contained in apple cider vinegar against the growth of S.epidermidis and P.acnes, in vitro. The study used the disc diffusion method by utilizing the Mueller Hinton Agar medium. The apple cider vinegar inhibition zone was formed at the concentration of 25%, 50%, 75%, and 100% against the growth of P.acnes, whereas the inhibition zone against S.epidermidis was formed at the concentration of 50%, 75%, and 100%. The highest inhibition zone against P. acnes was 8,825 mm and against S.epidermidis was 3,725 mm at the concentration of 75%. Test results One-way ANOVA on P.acnes and Kruskal Wallis to S.epidermidis obtained (p) <0,005. This study concludes the effectiveness of apple cider vinegar in inhibiting the growth of P. acnes and S. epidermidis, where the effectiveness against P. acnes was stronger than against S. epidermidis.","PeriodicalId":398630,"journal":{"name":"Journal of Research in Pharmacy and Pharmaceutical Sciences","volume":"82 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114493933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Research in Pharmacy and Pharmaceutical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1